Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • avtsanger
    Junior Member
    • Jun 2010
    • 8

    Various assemblers and getting them to work

    Hi

    I have been having a go at running different assemblers on a variety of bacterial genomes. So far Velvet and Abyss have been very simple to use and have given me some useful output. I am however having trouble with some of the other assemblers and I was hoping someone out there might be able to help.

    SOAPdenovo

    After having obtained the version from the author that allows kmer values of greater than 31, I tried running it on a 2.5mb genome consisting of 54 bp Illumina reads. Using a kmer value of 47 (obtained using the velvet optimisation script) and run successfully using Velvet and Abyss, I tried to run SOAPdenovo. However, I immediately ran into trouble as the memory requirements exceeded 30gb and my job was cancelled automatically. Is this to be expected with higher kmer values and SOAP?

    SSAKE

    I typically use fastq files that have already been quality filtered. Is there a way of feeding these directly in to SSAKE. I may be being slow but it wouldn't accept fastq files...

    ALLPATHS

    Is it possible to run the assembler without a jumping library?

    Any help would be gratefully appreciated.
  • francesco.vezzi
    Member
    • Jan 2009
    • 50

    #2
    Hi,
    SOAPdenovo: probably the data structures used by SOAPdenovo became too large with such big kmer, actually I'm a bit surprised that velvet is able to run with a kmer of size 47....
    Another aspect is the meaning of a such large kmer.... with the de bruijn graph approach use a kmer of 47 means that you are looking for perfect overlaps of length 46, and with read length of 54 this is really too much because as you know illumina reads usually have errors at the end of the reads.

    SSAKE:
    it use the seed and extend paradigm that is unable to assemble even short repeats, I will not suggest it. I have not tested the latest version but the last time that I used it I found it results not really good

    ALLPATHS:
    my question is "is possible to run ALLPATHS?".... I never succeed in installing and running allpaths, I tried everything....
    Every time that I spoke with other people that use de novo assembler they confirmed me that they were not able to use allpaths...

    Francesco

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    214 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    79 views
    0 reactions
    Last Post SEQadmin2  
    Working...